We are on the precipice of a looming crisis. Antimicrobial resistance (AMR) is the evolution of deadly pathogens like bacteria and fungi to resist all current antimicrobial medicines. In this episode, we talk about how the dwindling supply of new antibiotics is fueling this silent pandemic, and why we need a continued pipeline of new antibiotics to avoid this crisis.Guests:Ankit Mahadevia, Spero TherapeuticsHenry  Skinner, AMR Action FundMary Dwight, Cystic Fibrosis Foundation